Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 6,956 shares at $32.12 ($223K) on 2026-02-03, disclosed to the SEC on 2026-02-03.
Seasonal sale ($223k) by CHIEF MEDICAL OFFICER — this insider has traded TVTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-01-07 | $98K | — | Filing → |